Upstream Bio announces Phase 3 plans for Verekitug in two indications
Upstream Bio said it has pivotal Phase 3 development plans for Verekitug in severe asthma and CRSwNP.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.